Dysregulation in immune responses during pregnancy increases the risk of a having a child with an autism spectrum disorder (ASD). Asthma is one of the most common chronic diseases among pregnant women, and symptoms often worsen during pregnancy. We recently developed a mouse model of maternal allergic asthma (MAA) that induces changes in sociability, repetitive, and perseverative behaviors in the offspring. Since epigenetic changes help a static genome adapt to the maternal environment, activation of the immune system may epigenetically alter fetal microglia, the brain's resident immune cells. We therefore tested the hypothesis that epigenomic alterations to microglia may be involved in behavioral abnormalities observed in MAA offspring. We used the genome-wide approaches of whole genome bisulfite sequencing to examine DNA methylation and RNA sequencing to examine gene expression in microglia from juvenile MAA offspring. Differentially methylated regions were enriched for immune signaling pathways and important microglial developmental transcription factor binding motifs. Differential expression analysis identified genes involved in controlling microglial sensitivity to the environment and shaping neuronal connections in the developing brain. Differentially expressed genes significantly overlapped genes with altered expression in human ASD cortex, supporting a role for microglia in the pathogenesis of ASD. (Dolinoy, Weidman, & Jirtle, 2007; Jirtle & Skinner, 2007) . The developing mammalian brain is particularly sensitive to epigenetic alterations, as mutations in epigenetic effectors can result in human neurodevelopmental disorders (LaSalle, 2013; Vogel Ciernia & LaSalle, 2016) . Epigenetic changes are thought to adapt a static genome to a dynamic environment, providing an important interface between genetic and environmental risk factors in the complex etiology of autism spectrum disorders (ASDs).
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Epidemiological reports suggest a strong association between periods of maternal immune activation (MIA) during pregnancy and an with autoimmune and immunological conditions such allergy, asthma, celiac disease, type-1 diabetes, autoimmune thyroid disease, psoriasis, rheumatoid arthritis, and rheumatic fever have been reported (Atladottir et al., 2009; Croen, Grether, Yoshida, Odouli, & Van de Water, 2005; Keil et al., 2010; Mostafa & Kitchener, 2009; Mouridsen, Rich, Isager, & Nedergaard, 2007) , providing additional evidence for maternal immune dysfunction and increased risk of ASD.
Asthma is one of the most common chronic diseases among pregnant women. During pregnancy, the median percent of women hospitalized for acute exacerbations of asthma is 6% (Ali & Ulrik, 2013a,b; Murphy, Clifton, & Gibson, 2006; Murphy, Gibson, Talbot, & Clifton, 2005) ; however, in a study of 330 women with asthma, symptoms worsened in as many as 35% during pregnancy (Schatz et al., 1988) . A large epidemiological study demonstrated that mothers with new onset allergies and asthma during the time of pregnancy were at increased risk for having a child with ASD (Croen et al., 2005) . A separate study that looked at maternal allergies and asthma, irrespective of whether they were new onset or existing conditions, also found increased risk with certain allergies and ASD (Lyall, Ashwood, Van de Water, & Hertz-Picciotto, 2014) . Recently, we identified a profile of elevated serum cytokines midgestation in women who gave birth to a child later diagnosed with ASD (Goines et al., 2011; Jones et al., 2017) .
This cytokine profile of elevated interleukins IL-4 and IL-5 was consistent with an allergic asthma clinical phenotype (Cho, Stanciu, Holgate, & Johnston, 2005; Kumar, Webb, Herbert, & Foster, 2006; Magnan et al., 2000; Tamasi et al., 2005) . Furthermore, a different midgestation maternal cytokine profile of elevated IL-6 and IL-2 was associated with having a child with other developmental disorders, but not ASD (Goines et al., 2011) . Amniotic fluid taken from children later diagnosed with ASD also had elevated levels of IL-4 whereas those with developmental delay had increased levels of IL-6 (Abdallah et al., 2012) . These reports implicate asthma/allergy and associated cytokine responses as a potential contributing factor to the development of ASD.
Previous work in animal models examining the impact of gestational MIA on ASD-like behaviors of the offspring have focused on viral and bacterial responses, using polyinosinic-polycytidylic acid (polyI:C) or lipopolysaccharide (LPS) as experimental models (Nials & Uddin, 2008; Whitehead, Walker, Berman, Foster, & Schwartz, 2003) . However, allergies and asthma represent an alternative inflammatory response mediated by T-helper type 2 cells (T H 2) that produce a different cytokine profile that may uniquely alter brain development relevant to ASD. We recently developed the first preclinical model of maternal allergic asthma (MAA) that produces the hallmark immunological responses in the MAA treated dams analogous to those observed in humans, including allergic airway inflammation and elevated levels of IL-4 and IL-5 (Schwartzer, Careaga, Chang, Onore, & Ashwood, 2015) .
MAA produced a phenotype in the offspring of impaired social approach and increased repetitive behaviors at both juvenile and adult ages (Schwartzer et al., 2015 (Schwartzer et al., , 2017 ) that resemble behavioral features of ASD (Thomas et al., 2009) . MAA challenge in gestation also resulted in altered brain neurochemistry in offspring similar to those observed in ASD (Schwartzer et al., 2015) .
In humans, fetal exposure to maternal asthma led to epigenetic alterations in DNA methylation patterns in peripheral blood samples of the offspring (Gunawardhana et al., 2014) . Notably, hypomethylation in immune signaling gene MAP8KIP3 in fetal blood correlated with blood eosinophils, nitric oxide levels, and total serum IgE in the mother (Gunawardhana et al., 2014) , suggesting that human MAA responses may be related to additional epigenetic changes in the offspring. These findings are consistent with previous work which found histone acetylation (Tang, Jia, Kast, & Thomas, 2013) and DNA methylation (Basil et al., 2014; Richetto et al., 2016 ) changes in brain from juvenile and adult offspring in the polyI:C MIA mouse model. Together these results suggest that epigenetic changes within the immune cells of the brain may be responsible for the long-lived behavioral changes of offspring exposed to gestational MAA.
Within the brain microglia are brain-resident macrophages derived from erythromyeloid precursors from the embryonic yolk sac that contribute to brain homeostasis and shaping synaptic and long-range neuronal connections (Hashimoto et al., 2013; Paolicelli et al., 2011; Schafer et al., 2012; Tremblay, Lowery, & Majewska, 2010; Zhan et al., 2014) . Microglia monitor and respond to their environment via specific cell surface receptors and secreted molecules, thereby acting as sentinel cells of tissue stress and injury (Murray & Wynn, 2011) . The gestational timing of MAA may lead to alteration in microglial activity during key organizational phases of prenatal development producing long-lasting changes in neural circuitry. Microglia arise from the yolk sac myeloid progenitors, migrate to the brain and colonize the neural folds during embryogenesis with minimal replacement from peripheral monocytes (Squarzoni, 2015) , suggesting that any perturbations to microglia in early development may also persist through adulthood. To test the hypothesis that gestational MAA is associated with long-lived ASD-relevant epigenetic changes in microglia, we performed genome-wide analyses of the DNA methylome and transcriptome of microglia isolated from juvenile offspring. The results of this study provide genome-wide evidence that gestational MAA alters DNA methylation of key immune regulatory elements and transcription of genes dysregulated in human ASD brain, supporting the validity of the MAA mouse model, microglia as a relevant cell type, and maternal asthma as an ASD risk factor.
| M A TER I A LS A N D M ETH OD S

| Animals
All experiments used C57Bl/6J mice from Jackson (Jax strain 000664).
All experiments were conducted in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals.
All procedures were approved by the Institutional Animal Care and Use Committee of the University of California, Davis.
| Maternal allergic asthma paradigm
The MAA paradigm was conducted as previously described (Schwartzer et al., 2015 (Schwartzer et al., , 2017 . Briefly, on postnatal day (P) 42 and 49 sexually naive female C57Bl/6J mice were sensitized with a single intraperitoneal injection of 10 lg ovalbumin (OVA, Sigma, St. Louis, MO) in 1 mg (Al)OH 3 (InvivoGen, San Diego, CA) dissolved in 200 lL phosphate buffered saline (PBS). One week following the second sensitization treatment, female mice were mated overnight and checked daily for the presence of a seminal plug, noted as gestational day 0.5 (G0.5). Pregnant mice were randomly assigned to either the allergic asthma or control group and exposed to either an aerosolized solution of 1% (w/v) OVA in PBS (MAA group) or vehicle control for three 45-min induction on gestational days 9.5, 12.5, and 17.5, to correspond with early, middle, and late gestation. Following the final induction, mice were returned to their home cages, single housed, and left undisturbed until the birth of their litters. Pups remained with their mother until weaning on P21, at which time the offspring were group housed with same-sex littermates. For all experiments, female offspring were chosen for analysis due to previously identified increased microglial reactivity at P30 in females compared with males (Schwarz, Sholar, & Bilbo, 2012) .
Female MAA offspring also show a similar behavioral phenotype to male MAA offspring with deficits in social interactions, increased marble burying and decreased grooming (Schwartzer et al., 2015 (Schwartzer et al., , 2017 Figure S1 ). 
| RNA sequencing principal component analysis
Principal component analysis (PCA) was conducted on read counts from published cell type specific RNA sequencing (Mo et al., 2015; Zhang et al., 2014 ) with normalization for library size. Raw Fastq files for each cell type were downloaded from GEO (GSE63137 and GSE52564) and processed as described except for paired end sequencing. PCA was conducted on the top 500 most variably expressed genes across all cell types using custom R scripts. To further assess microglial purity subsampling of the aligned reads for both neuronal and microglial samples (Zhang et al., 2014 ; GEO GSE52564) were performed to match the average 3 3 10 7 reads/sample (Supporting Information Figure S1 .
| RNA sequencing differential expression analysis
RNA-seq reads were aligned to the current mouse genome mm10 using the splicing-aware aligner Tophat2 (v2.0.14/bowtie2.2.5, stranded, Single End; Kim et al., 2013) and reads aligning to each gene were counted using FeatureCounts (Liao, Smyth, & Shi, 2014 ) with exclusion of multimapping reads. The resulting table of counts per gene per sample was analyzed using the EdgeR pipeline (Robinson, McCarthy, & Smyth, 2010) . Lowly expressed genes (less than 1 count per million reads in at least three biological replicates from either MAA or PBS groups) were removed from the analysis and the remaining reads were normalized for library size and RNA composition using the calcNormFactors function with trimmed mean of M-size method (Robinson & Oshlack, 2010 ). The normalized libraries were then fed into a one factor model (MAA vs. PBS) with a zero intercept. Both common and tagwise dispersions were estimated using estimateDisp and the resulting model was used for differential expression using exactTest and topTags Sequencing of barcoded and pooled libraries was performed across two lanes of Illumina HiSeq4000 to obtain 100 bp single end reads.
After adapter trimming and quality assessment, all WGBS reads were mapped to the mouse genome (mm10) using the Bisulfite Seeker2 program (v2.0.8 with bowtie1.1.1; Guo et al., 2013) and subsequent analysis was done with custom Perl and R scripts (Dunaway, Islam, et al., 2016) . Differentially methylated regions (DMRs) between experimental conditions were examined using the R packages DSS and bsseq (Feng, Conneely, & Wu, 2014) . DMRs were identified as sets of CpGs with a t statistic greater than the critical value for alpha 0.05 and with a gap between CpGs of less than 300 bases. DMRs were then filtered for those with more than 3 CpGs, a mean methylation difference of greater than or equal to 10% between conditions, and an area stat of 620. Further permutation testing was used to identify DMRs with a family wise error rate <0.05 based on 1,000 permutations of random shuffling of sample group assignment. The average difference in methylation was 29.94% for hypermethylated and 31.57% for hypomethy- Global assessment of CpG and CpH methylation levels was performed between groups using a two-tailed t-test. CpG methylation over gene bodies, promoters, CpG islands, and CpG island shores (62 kb from a CpG island) was assessed by a two way repeated measures ANOVA.
| WGBS PCA
PCA was conducted on percent mCG/CG from publish cell type specific WGBS (Lister et al., 2013; Mo et al., 2015) . Raw Fastq files for each cell type were downloaded from GEO (GSE63137 and GSE47966) and processed as described for WGBS. Percent CG/CG methylation was extracted for 20 kb windows, gene bodies, and CpG islands for each sample. CpG Islands were masked from the analysis of the other two regions. PCA was conducted on the top 500 most variable regions of each type for all cell types using custom R scripts.
| Fluidigm Biomark HD Delta Gene Expression assay
Gene expression for selected targets identified from RNAseq analysis were examined in an independent set of microglial samples isolated from PND35 female littermates of animals used for sequencing (Supporting Information Table S3 ). Gene expression analysis was performed using the Fluidigm Biomark HD Delta Gene assay on a 48.48 Integrated Fluidic Circuit. Delta gene assay design was performed by Fluidigm and primer sequences are listed in Supporting Information Table   S3 . Total RNA (20 ng) was used as input for cDNA synthesis (Fluidigm, 100-6472 B1) followed by preamplification (13 ng per sample; Fluidigm, 100-5875 C1) using a mix of all forward and reverse primers.
Samples were then diluted fivefold and analyzed on a 48.48 IFC and Biomark HD machine (1.4 ng/sample) in duplicate (Fluidigm, 100-9791 B1). Cycle threshold values were averaged across replicates and then normalized to hprt expression (no difference in mean Ct values for hprt between conditions, t 5 1.27, p 5 .239) using the delta Ct method (Ct gene -Ct hprt). These values were then used for group comparisons with a two-tailed t test without an assumption of equal variance. For display purposes, the delta delta Ct values were then calculated relative to the average Ct value of the PBS treated control for each gene, and relative expression levels were then calculated for each group by 2^-delta delta Ct (Supporting Information Figure S4D ).
| Overlap of gene lists
Gene list overlap was performed using the GeneOverlap (Shen, 2013) package in R with a Fisher's exact test and a false discovery rate correction to p 5 .05. Gene lists and references are listed in Supporting Information Table S7 (Cotney et al., 2015; Cronk et al., 2015; Dunaway, Islam, et al., 2016; Garbett, Hsiao, Kalman, Patterson, & Mirnics, 2012; Gilissen et al., 2014; Gunawardhana et al., 2014; Gupta et al., 2014; Holtman et al., 2015; Iossifov et al., 2014; Lombardo et genome.wustl.edu; Dunaway, Islam, et al., 2016) . Figure 1a shows the experimental design prior to microglial isolation.
| R E SU LTS
To induce a MAA response, female mice were presensitized with OVA exposure at 6 and 7 weeks of age prior to breeding. Timed pregnant dams were then given three exposures to OVA during gestation (gestation day 9.5, 12.5, and 17.5) or three exposures to endotoxin free PBS to mimic immune challenge respectively (Schwartzer et al., 2015) .
While ASD has a pronounced sex-bias for males, both male and female MAA offspring show similar behavioral deficits in social interactions, increased marble burying, and decreased grooming (Schwartzer et al., 2015 (Schwartzer et al., , 2017 . In rodents, adolescent females show increased microglial reactivity compared with males (Schwarz et al., 2012) . Consequently, this study focused on characterizing juvenile microglia from female MAA offspring. In order to study the effects of in utero MAA on persistent microglial epigenomic signatures that coincide with the observance of ASD-like behaviors (Schwartzer et al., 2015 (Schwartzer et al., , 2017 , microglia were isolated from juvenile mice from multiple litters (n 5 4 mice from a total of four litters per condition) on P35. There were no significant differences in the number of microglia isolated or the RNA/ DNA yields between the two treatment groups (Supporting Information Table S1 ).
3.1 | Microglial methylome and transcriptome reveal cell type specific signatures RNA sequencing was performed to examine differences in gene expression associated with MAA in juvenile microglia (n 5 4/group).
There were on average 28.6 million uniquely mapped reads per sample and no differences in read depth or mapping between conditions (Supporting Information Table S2 ). All libraries passed FastQC assessment and none indicated significant sources of contamination during library preparation (Supporting Information Figure S1A ,B).
We first sought to ensure that the gene expression patterns in Figure   2b ). In addition, subsampling microglial and neuronal reads from previously published RNAseq (Zhang et al., 2014) indicated that the percentage of neuronal RNA contamination in our microglial samples was minimal and between 0.2 and 4% (Supporting Information Figure S1C ).
Analysis by flow cytometry on samples prepared in parallel indicate a similar purity greater than 90% (Supporting Information Figure S1D ).
To examine DNA methylation changes in P35 microglia between MAA and PBS treated samples using an unbiased genome-wide approach, we performed WGBS. There were no significant differences in sequencing coverage, bisulfite conversion, or in the global percentage of CG, CHG, or CHH methylation between treatments (Supporting Information Table S2 ). On average microglia showed similar levels of mCG and mCH as previously described in neurons (Lister et al., 2009 ).
To examine cell type specific methylation patterns, we compared 20 kb windows across the genome from the MAA and PBS microglia collected in this experiment to previously published WGBS data on several specific types of neurons (excitatory, PV interneurons and VIP interneurons; Mo et al., 2015) , astrocytes, and brain (P28; Lister et al., 2013 show a distinct methylation pattern from other brain cell types (Figure 2c ). Similar patterns were observed over gene bodies and to a lesser extent over CpG islands (Supporting Information Figure S2A ,B). There were no significant differences between MAA and PBS treatment groups in average percent CG methylation for a number of global genomic features, including gene bodies, 5 kb upstream promoter regions (with or without CpG islands), nor CpG islands (Supporting Information Figure S2C ).
| Differentially methylated regions in MAA offspring microglia
To assess the long-term impact of MAA on epigenetic regulation in offspring microglia we identified locus-specific DMRs between MAA and PBS (Dunaway, Goorha, et al., 2016; Dunaway, Islam, et al., 2016) .
DMRs (1,184) were identified, with nearly equivalent numbers of hypermethylated (626 MAA > PBS) and hypomethylated (558 PBS > MAA) regions (Figure 3a and Supporting Information Table S3 ).
Three DMRs also passed family wise error rate (FWER) correction (Supporting Information Figure S2D ). In general, MAA associated DMRs were largely localized within introns (40%) and intergenic sites (26%; Figure 3b ) indicating potential regulatory function.
Functional annotation was assigned to each DMR using GREAT, which included biological processes such as regulation of cell number, Mo et al., 2015) , astrocytes and total fetal cortex (P28; Lister et al., 2013) . CpG Islands were masked from the analysis Supporting Information Table S5 ) were significantly enriched for genes responsive to LPS, and other immune stimuli in microglia (Figure 3d ; Hanamsagar et al., 2017; Hickman et al., 2013; Holtman et al., 2015) .
Together these findings indicate that regions sensitive to MAA methylation differences may contain critical regulatory regions responsive to immune stimuli in microglia.
To evaluate potential transcription factor binding sites enriched within MAA-DMRs, we examined motif enrichment analysis using HOMER (Supporting Information 
| Differentially expressed genes in MAA offspring microglia
In order to understand how epigenomic differences in MAA offspring microglia were related to regulation of gene expression, we examined differential gene expression patterns from the same microglial isolations that were profiled for DNA methylation. Differential expression between MAA and PBS samples was conducted using the standard EdgeR pipeline and revealed 162 differentially expressed genes at an (Hickman et al., 2013) , primed microglia, genes upregulated acutely in response to LPS (Holtman et al., 2015) , and genes upregulated in microglia 2 hr after LPS in males and females at postnatal day 60 (P60; Hanamsagar et al., 2017) . See Supporting Information Table S7 Table S5 ). The vast majority of these genes showed greater expression in MAA samples compared with PBS (157 MAA > PBS). Gene Ontology enrichment analysis revealed significant enrichment of several categories of GO terms including gated and ion channel activity, synapse part, and regulation of cell projection organization (Supporting Information Figure   S3A and Supporting Information Table S6 ). Pathway enrichment using KEGG, Panther and Reactome revealed significant enrichment for pathways involved in a number of processes critical for neurodevelopment including several neurotransmitter systems, axon guidance, and synapse function (Supporting Information Table S6 ). While many of these gene targets are typically examined in neurons, microglia express GABA B , serotonin and dopamine, NMDA, AMAP, and kainic acid and metabotropic glutamate receptors that can be utilized to sample the local environment and consequently regulate activation, chemotaxis, secretion, proliferation, and phagocytosis (Black & Waxman, 2012; Craner et al., 2005; Li et al., 2008; Stebbing, Cottee, & Rana, 2015) . Gene expression changes were further validated on an independent group of microglial samples using a Fluidigm Delta Gene Expression assay on a selected subset of transcripts (Supporting Information Table S3B ). With this independent method and cohort all transcripts validated the direction of expression change seen in the sequencing cohort (Supporting Information Table S5 ) with Hspalb levels reaching significance (p < . 05) and Ina levels approaching significant (p < .07; Supporting Information Figure S3B ). Gilissen et al., 2014; Iossifov et al., 2014; Sanders et al., 2012 Sanders et al., , 2015 ; Figure 5a and Supporting Information Table S7 ). Genes that were differentially expressed and genes that were associated with DMRs in MAA microglia significantly overlapped a hand curated list of SFARI ASD risk genes and genes with Likely Gene Disrupting (LGD) mutations in exome sequencing from ASD probands (Iossifov et al., 2014) . However, the majority of known genetic risk factors were not found within the MAA microglial gene lists, suggesting that MAA is largely targeting gene pathways independently impacted by genetic mutations linked to ASD and ID. This is not surprising given that the majority of genetic risk factors for ASD and ID are not immune related (Needleman & Mcallister, 2012; Sanders et al., 2015) . However, differences in gene expression profiling from human ASD brain have revealed changes in expression of immune signaling pathways and microglial genes (Gupta et al., 2014; Parikshak et al., 2016; Voineagu et al., 2011) . To test the hypothesis that MAA microglia may show similar alterations in gene expression as human ASD brain samples, we overlapped the MAA microglial dysregulated genes with genes that showed altered expression or differential epigenomic marks (DNA methylation or histone acetylation) in human ASD brain samples (Dunaway, Islam, et al., 2016; Gupta et al., 2014; Parikshak et al., 2016; Sun et al., 2016; Voineagu et al., 2011; Figure 5b ). Differentially expressed genes in MAA microglia significantly overlapped genes with lower expression in both idiopathic and genetic (15q11-13 duplication) forms of ASD as well as genes with increased acetylation.
Furthermore, both MAA differentially expressed and DMR associated genes showed enrichment in a number of modules identified from network analysis of differential ASD gene expression from human ASD cortex (Gupta et al., 2014; Parikshak et al., 2016 ; Figure 5c and Supporting Information Table S7) induced MIA has also been previously observed (Lombardo et al., 2017) , suggesting that FMRP target genes may be specifically vulnerable to maternal inflammation. There was no significant overlap between either MAA gene list and identified CHD8 target genes from multiple data sets (Cotney et al., 2015; Sugathan et al., 2014) . MAA DMR associated genes were enriched in MeCP2 target genes identified from high resolution ChIP sequencing from olfactory epithelium neurons (Rube et al., 2016) , suggesting MeCP2 may be associated with sites of MAA differential methylation. MeCP2 has previously been implicated in microglial function in Rett syndrome (Cronk et al., 2015; Derecki et al., 2012; Schafer & Stevens, 2015) , and microglia from Rett mouse models show altered gene expression patterns related to glucocorticoid signaling and stress response (Cronk et al., 2015; Zhao et al., 2017) .
Genes differentially expressed in Rett syndrome mouse model microglia overlapped both MAA differentially expressed and DMR associated genes ( Figure 5e and Supporting Information Table S7 Figure   S4B and Supporting Information Table S7 ). The one exception to this was a significant overlap with genes acutely downregulated in response to LPS MIA. There were mixed findings for gene overlap with microglia isolated from PolyI:C MIA models. MAA microglial gene lists did not overlap dysregulated genes identified in a PolyI:C MIA model from isolated microglia from whole brain on P0 or P28 (Matcovitch-Natan et al., 2016; Supporting Information Figure S4B ). However, MAA differentially expressed genes significantly overlapped with genes that were upregulated in a PolyI:C MIA model from hippocampal microglia from adult animals (Mattei et al., 2017 ; Supporting Information Figure S4C) suggesting that MAA may impact hippocampal microglia. Interestingly, both MAA differentially expressed and DMR associated gene lists overlapped genes that were responsive to minocycline treatment in adult MIA animals (Mattei et al., 2017 ; Supporting Information Figure S4C ), indicating that minocycline may serve as a potential therapeutic for reversing some of the MAA offspring phenotypes.
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FIG URE 5 MAA differentially expressed and DMR associated genes overlap genes dysregulated in ASD. (a) Gene list overlaps between MAA differentially expressed genes (MAA DE genes), MAA DMR associated genes (MAA DMR genes), and ASD genetic risk genes (Gilissen et al., 2014; Iossifov et al., 2014; Sanders et al., 2012 Sanders et al., , 2015 . (b) Gene list overlaps between MAA DE genes, MAA DMR associated genes and genes differentially expressed, methylated, or acetylated in human ASD brain samples (Dunaway, Islam, et al., 2016; Gupta et al., 2014; Parikshak et al., 2016; Sun et al., 2016; Voineagu et al., 2011) . (c) Gene list overlaps between MAA genes and genes identified in gene expression network analysis with differential module membership for ASD and Control human cortex samples (Gupt et al., 2014; Parikshak et al., 2016) . (d) Gene list overlaps between MAA DE genes, MAA DMR associated genes and MeCP2, FMRP, or CHD8 target genes (Cotney et al., 2015; Darnell et al., 2011; Rube et al., 2016; Sugathan et al., 2014) . (e) Gene list overlaps between MAA DE genes, MAA DMR associated genes and genes differentially expressed in microglia from Rett syndrome mouse models (Cronk et al., 2015; Zhao et al., 2017) . Lists are from MeCP2 -/y null males (fully symptomatic), MeCP2 -/1 heterozygous females at either 5 weeks (prior to symptom onset) or at 24 weeks (fully symptomatic). The gestational timing of MAA may preferentially affect changes in microglial function in offspring, a perturbation that may be marked by changes in DNA methylation that persist as microglia develop. Microglia migration to the brain and colonization of the neural folds during embryogenesis with minimal turnover (Squarzoni, 2015) , suggesting that perturbations to microglia in early development may be maintained throughout the lifetime of the animal. Previous work with PolyI:C MIA demonstrated long-lasting alterations in histone modifications (Tang et al., 2013) and DNA methylation (Basil et al., 2014; Richetto, Calabrese, Riva, & Meyer, 2014; Richetto et al., 2016) signaling is consistent with the cytokine profile of elevated IL-4 and IL-5 observed in asthma (Cho et al., 2005; Kumar et al., 2006; Magnan et al., 2000; Tamasi et al., 2005) , the midgestation serum cytokines profiles observed in women who gave birth to a child later diagnosed with ASD (Goines et al., 2011; Jones et al., 2017) , and in amniotic fluid taken from children later diagnosed with ASD (Abdallah et al., 2012) . Similarly, the enrichment of DMRs for a number of transcription factor motifs critical for early development of microglia (RUNX1, PU.1, and IRF8) indicate that MAA may shift the developmental regulation of microglial function. For example, RUNX1 is expressed in microglial yolk sac progenitors and plays a critical role in regulating microglial proliferation in early brain development (Ginhoux et al., 2010) by ensuring that developing microglia transition from an amoeboid to mature, ramified state during differentiation (Zusso et al., 2012) . Similarly, PU.1 is a pioneer transcription factor with DNA methylation sensitive binding (Stephens & Poon, 2016) critical for microglia progenitor development (Goldmann et al., 2016; Kierdorf et al., 2013) , regulates microglia specific enhancers (Gosselin et al., 2014) and gene expression (Satoh, Asahina, Kitano, & Kino, 2014) . PU.1 shows increased expression in human ASD brain (Gupta et al., 2014) , and manipulations of PU.1 alter the expression of key microglial genes and phagocytosis function (Huang et al., 2017) , indicating that changes in PU.1 binding could dramatically alter microglial function in ASD. Future studies will be needed to examine the impact of MAA on microglia from different stages of development and in altering the transcriptional response to secondary immune activation (i.e., LPS).
In human ASD brain samples, whole genome analysis has identified alterations in DNA methylation (Dunaway, Islam, et al., 2016; Nardone et al., 2014) and gene expression (Gupta et al., 2014; Voineagu et al., 2011; Werling, Parikshak, & Geschwind, 2016 ) of a number of immune related genes including components of the complement cascade C1Q, C3, ITGB2, and the cytokine TNFa. Several studies have identified alterations in microglia morphology and density in postmortem brain samples from ASD patients (Morgan, Barger, Amaral, & Schumann, 2014; Morgan et al., 2010 Morgan et al., , 2012 Tetreault et al., 2012; Vargas, Nascimbene, Krishnan, Zimmerman, & Pardo, 2005) . In at least a subset of ASD cases, microglia adopt an immune activated morphology characterized by retraction and thickening of processes and enlargement of the soma in multiple brain regions including the dorsolateral prefrontal cortex (Morgan et al., 2010) , amygdala (Morgan et al., 2014) , and cerebellum (Vargas et al., 2005) . Using positron emission tomography and a radiotracer for microglia, Suzuki et al. (2013) found evidence for increased microglia activation in multiple brain regions in young adults with ASD.
Given that immune system related genes are not highly prevalent among the genetic candidates for ASD risk, the alterations in expres- The vast majority of differentially expressed genes in MAA microglia showed a significant increase in expression relative to PBS controls.
While not expected, this increase in expression is consistent with other MIA experiments in whole brain examining acute responses to MIA treatments (Garbett et al., 2012) Eder, 1998; Li et al., 2008; Schilling & Eder, 2007 Stebbing et al., 2015; Wu, Kaur, Sivakumar, Lu, & Ling, 2009) (Squarzoni et al., 2014) , and alterations in glutamatergic synapses in the adult offspring (Roumier et al., 2008) . Our results show that MAA microglia have significant transcriptional and epigenetic alterations to genes important in axon guidance and receptor function that are consistent with altered sensitivity to the environment and neuronal circuit development.
One potential limitation of our study was a low level of neuronal contamination (0.2-2% in control versus 0.5-4% in MAA, Supporting
Information Figure S1C ) in our microglial isolations due to the inherent microglial-neuronal interactions including phagocytosis that occur in brain. While our microglia isolations were above the purity of another published microglial transcriptome study (Zhao et al., 2017) , we cannot be certain that the higher expression of some of the typically neuronal genes were cell intrinsic to microglia rather than a result of increased phagocytosis of neurons in the MAA brain (Solga et al., 2015) , although either explanation is of interest for understanding the pathogenesis.
While the function of many of these neurotransmitter receptors on microglia is largely unknown (Schafer, Lehrman, & Stevens, 2013) , their overall increase in expression following MAA suggests that microglia have altered sensitivity in the juvenile MAA brain. This is consistent with recent work from a PolyI:C MIA model that showed altered gene expression of cell surface receptors and phagocytosis activity of adult hippocampal microglia (Mattei et al., 2017) . Genes misregulated in this model overlapped the MAA differentially expressed genes indicating shared molecular pathways and functions may be disrupted. In addition, MAA impacted genes also overlapped genes responsive to adult minocycline treatment in this MIA model, suggesting minocycline may be able to similarly reverse the behavioral, gene expression and microglial functional deficits in the MAA offspring. Alternatively, many of the receptors showing increased expression in MAA offspring microglia are identified drug targets for a variety of pharmaceuticals (Supporting Information Table S6 ) that may provide novel options for therapeutics, as is being explored in other neurologic disorders (Eder, 2010) .
This work provides a novel link between MAA and changes in the microglial epigenome, indicating that microglia may serve as a potential therapeutic target for normalizing fetal brain connectivity deficits observed in ASD. Removal of microglia from the adult mouse brain by pharmacological treatment did not negatively impact adult behavior (Elmore et al., 2014; Elmore, Lee, West, & Green, 2015) and improved behavioral deficits in an Alzheimer's disease model (Rice et al., 2015) , 
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